Q4 FY23 Financial Press Release
Source link
Q2 FY24 Financial Press Release
Q2 FY24 Financial Press Release Source link
Q4 FY23 Financial Press Release
0
Related News
Q3 FY23 Financial Press Release
Q3 FY23 Financial Press Release Source link
Sun Pharma and Zydus sign licensing agreement for co-marketing of Desidustat in India
Sun Pharma and Zydus sign licensing agreement for co-marketing of Desidustat in India Source link
Sun Pharma to announce second quarter results on November 01, 2023
Sun Pharma to announce second quarter results on November 01, 2023 Source link
Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma
Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival...
CEQUA® (cyclosporine ophthalmic solution) 0.09% Phase 4 Data Showed Sustained Improvement in Dry Eye Disease Signs and Symptoms in Patients Switched From Restasis® (cyclosporine ophthalmic emulsion) 0.05%
CEQUA® (cyclosporine ophthalmic solution) 0.09% Phase 4 Data Showed Sustained Improvement in Dry Eye Disease Signs and Symptoms in Patients...
ADANI Adani Enterprises Aditya Birla Group Airtel Ambuja Cement Apollo Hospitals Apple Inc Bank of America Cigna Corporation Cognizant India Dalmia Bharat Exxon Mobil FedEx Corp General Electric Godrej Group Hindustan Zinc Home Depot ICICI Bank Indian Bank Infosys KEC Inter Kubota Corporation L&T Mahindra & Mahindra Meta Platforms Microsoft National Aluminium Company Nestle India Royal Dutch Shell Samsung Global Saudi Aramco Standard Chartered Bank Steel Authority of India Sun Pharma Target Corporation Tata Chemicals Tata Consumer Products Tata Motors Tata Power Tata Steel Tcs UltraTech UltraTech Limited Verizon Communications Voltas Limited
© 2022 incPres.com